Home
Conditions
Recurrent Pancreatic Cancer

Clinical trial condition

Recurrent Pancreatic Cancer

Explore clinical trials studying Recurrent Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

43 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Pancreatic Cancer trial results

Completed

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

NCT02153450

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

NCT01473940

Conditions: Digestive System Diseases, Digestive System Neoplasms, Duct Cell Adenocarcinoma of the Pancreas, +9 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

NCT01846520

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +137 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

NCT01806675

Conditions: Adenocarcinoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, +123 more
Locations: Stanford University, School of Medicine Stanford, California, United States

View Trial Details

Completed

Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery

NCT01537107

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Mayo Clinic Campus in Arizona Scottsdale, Arizona, United States

Mayo Clinic Campus in Florida Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

NCT00735917

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Colorado at Denver Aurora, Colorado, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT01839981

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

NCT02166255

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +40 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

NCT01234935

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations: Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States

TORI FULLERTON (St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center) Fullerton, California, United States

Pacific Shores Medical Group Long Beach, California, United States

UCLA medical center Los Angeles, California, United States

View all 17 locations

View Trial Details

Completed

Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

NCT00383760

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Recurrent Pancreatic Cancer

Recurrent Pancreatic Cancer trial results

Related conditions